The biggest challenge in patients with newly diagnosed PCa is shifting from cancer detection or staging alone to identifying them with aggressive disease. The PI-RADS v 2 recognizes the role of DCE-MRI is limited but is essential. This work presented a radiology pathology correlation framework that enabled identification of promising in vivo DCE MRI markers of PCa risk at voxel level. The relationship between ISUP grade and DCE-MRI (Ktrans and Kep) suggests that it may be used as a component of active surveillance to noninvasively detect high-grade PCa and affect staging and treatment.
This abstract and the presentation materials are available to members only; a login is required.